CITIUS ONCOLOGY, INC. (CTOR): debt financing — TenX Keane Acquisition extends deadline to Jan 18, 2024; deposits $660K

CITIUS ONCOLOGY, INC.

Deposited $660,000 ($0.10 per public share) into trust to extend combination deadline to January 18, 2024.
Sponsor 10XYZ Holdings LP provided the extension fee via an unsecured promissory note.
Sponsor may convert up to $1.5M of the note into private units at $10.00 per unit (one share + 2/10 right per unit).
Company had until October 18, 2023 to complete initial business combination prior to extension.
Extension is the first of two possible three-month extensions permitted under the charter.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

CITIUS ONCOLOGY, INC. incurred loan of $660,000 with 10XYZ Holdings LP at no interest maturing due upon consummation of business combination.

Instrument: loan
Principal: $660,000
Counterparty: 10XYZ Holdings LP
Rate: no interest
Maturity: due upon consummation of business combination
Event: incurrence

Exact text from the filing

On October 18, 2023, the Company deposited $660,000 into the trust account of the Company (the “Extension Fee”) to extend the timeline to complete a business combination for an additional three months from October 18, 2023 to January 18, 2024 (the “Extension”). Such deposit of the Extension Fee is evidenced by an unsecured promissory note (the “Promissory Note”) in the principal amount of $660,000 to the Sponsor.

View on SEC.gov

7 debt financings filed in the last 30 days. Browse all debt financings →

CITIUS ONCOLOGY, INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-037635

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.